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Hypoxic Preconditioning as 
a Strategy to Maintain the 
Regenerative Potential of 
Mesenchymal Stem Cells
Bushra Bashir, Mahmood S. Choudhery and Ijaz Hussain
Abstract
Mesenchymal stem cells (MSCs) are non-hematopoietic cells with high proliferative 
potential and multi-lineage differentiation capacity. MSCs are promising therapeutic 
candidates for cell-based therapies, and hundreds of clinical trials have been regis-
tered using these cells. Potential of stem cells is compromised with the factors such as 
disease condition and age of donor. Therefore, taking the cells from such patients for 
autologous use may compromise the benefits of cell-based therapies. It is therefore 
required to enhance the potential of these cells before use in stem cell-based therapies. 
Optimization of culture conditions is preferred strategies to enhance the regenerative 
potential of cells before use. This chapter briefly overviews the benefits of hypoxic 
preconditioning of stem cells to enhance the regenerative potential of cells in terms of 
their survival, proliferation, and differentiation.
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1. Introduction
Clinical use of stem cells is rapidly growing in recent years because of their 
capabilities to repair and regenerate tissues and organs of body [1]. Stem cells have 
self-renewal potential and can differentiate into cells of multiple lineages under 
appropriate conditions. They can secrete a large number of bioactive molecules 
that are involved in repair and regeneration of damaged tissues and organs. Based 
on their potential, stem cells are classified as totipotent, pluripotent, multipotent 
and unipotent. Fertilized eggs (zygote) are totipotent as they can make cells of all 
three lineages and extra embryonic tissue such as placenta. Embryonic stem cells 
(ESC) are derived from inner cell mass of 5 days old embryos and are pluripotent 
as they have potential to differentiate into all cells and tissues of the body except 
placenta. MSC are the most widely used cells and they can be isolated from various 
adult body tissues (bone marrow, adipose tissue, articular cartilage, synovium, 
synovial fluid, dental pulp, etc.) as well as from neonatal stem cell sources (cord 
blood, cord tissue, placenta) [2]. Currently, hundreds of clinical trials have been 
registered using MSCs (www.clinicaltrials.org) for various conditions such as 
degenerative brain disorders, stroke, cardiac dysfunctions, myocardial ischemia, 
renal disorders, wound healing, diabetes etc. [3]. MSCs exert their effect either by 
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transdifferentiation into respective tissues and/or through their paracrine effects by 
releasing different cytokines and growth factors [4].
The potential of adult stem cells such as MSCs is severely compromised in vitro 
by culture conditions and by number of passages of the cells [5]. In addition, “disease 
conditions” and “age” of the donor also reduces regenerative functionality of MSCs 
and their clinical use for repair and regeneration of damaged and lost tissues [6]. It is 
pertinent to note that elderly population is the main portion of population for potential 
stem cell-based regenerative therapies. However, autologous use of cells from aged 
individuals seems not to provide the expected benefits of stem cell-based therapies 
due to age depleted function of stem cells from such patients [7]. It is therefore 
required to enhance the potential of stem cells before clinical use. Different strategies 
have been employed for this purpose such as growth factors preconditioning [8], mild 
heat shock [9], and glucose depletion [10].
Different pretreatment strategies have been employed to enhance the regenerative 
potential of stem cells, however; hypoxic preconditioning seems more effective for 
enhancing stem cell function because relatively low oxygen concentrations prevail in 
stem cells niches as compared to normoxic conditions. Hypoxia can be an effective 
strategy for enhancing the cells function because it can make the cells adapt external 
microenvironment, reduce oxidative stress, shift metabolism towards glycolysis, 
enhance proliferation, differentiation and maintain stemness, and improve their 
motility to tolerate the hypoxic preconditioning after transplantation [11].
2. Regenerative potential of stem cells is compromised with age
2.1 Effect of donor age on regenerative potential of stem cells
Autologous stem cell-based therapies seem promising for several diseases. 
As humans get older, stem cell function deteriorate like other cells of the body. 
Diseases, especially degenerative diseases generally affect elderly people and 
therefore using autologous cells for such patients may have practical concerns [12]. 
With aging, superoxide dismutase activity (SOD) declines [13]. Studies indicate 
that differentiation potential of stem cells is negatively related with age of donor 
[12, 14–16], and therefore cell potential to form osteoblasts [12, 15–17], cartilage 
[12, 14–16] and other cell types is compromised. Another important aspect for 
cell-based therapies, that is, proliferation is also adversely effected with increasing 
donor age. Choudhery et al. [15] indicated that the number of population doublings 
decreased while the time of population doublings increased for cells obtained from 
aged donors as compared to cells from the young donors. Similarly, number of the 
colony forming units, size of colonies and plating efficiency of aged cells decreases 
in vitro [13–17]. Overall, growth kinetics and differentiation potential of the cells 
are inversely proportion to the donor age [15–18].
2.2 Effect of in vitro passaging
Cell-based therapies require large number of cells to get the favorable results in 
patients. For this purpose cells are expanded in vitro before use in most of clinical 
applications [12]. Leonard Hayflick in 1960 described that after a limited number 
of cell divisions the cells stop dividing. Cell morphology changes and they become 
enlarged and irregular in shape. The cells undergo a replicative senescence and 
this limited life span of cells is called as Hayflick’s limit [19]. In this way replica-
tive senescence limits the therapeutic potential of stem cells. The differentiation 
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potential of cells decreases with increasing number of in vitro passages. For 
example, bone marrow derived MSC showed decreased differentiation towards 
adipogenesis, osteogenesis and chondrogensis at late passages as compared to 
initial passages [20]. In addition, the proliferative potential of MSCs decreases after 
long term passages [21]. Human Wharton’s jelly-derived mesenchymal stem cells 
showed significant decrease in growth kinetics and differentiation when cultured 
for longer time as compared to the cells in initial passages [22]. Feline adipose tissue 
derived MSC showed a progressive decrease in pluripotency and proliferation over 
continuous passaging [23].
3. Oxygen levels vary in tissues
The structural and functional microenvironment in tissues where stem cells 
reside is known as stem cell niche described for the first time by Schofield [24]. A 
cell niche maintains the identity and functional characteristics of resident cells [25]. 
Important identified stem cell niches are in bone marrow [26], vascular vessels [27], 
liver [28] adult kidneys [29] intestine [30] endometrium [31], oral tissue [32], skin 
[33] and adipose tissue [34]. Table 1 shows variable oxygen concentrations in some 
important stem cell niches.
Organ/tissues PO2 
values
References
Lungs (tracheal, bronchial, bronchiolar and alveolar epithelial cells) 13–14% [35]
Subcutaneous 3–8% [36]
Adipose tissue 3–10% [37, 38]
Heart 2–6% [39]
Brain (superficial cortex to deep white matter) 3–5% [40]
Brain (hypothalamus, hippocampus, midbrain) 0.5% [40]
Liver (parenchyma) 4–7% [41]
Kidney (renal cortex) 4–9.5% [42]
Kidney (medulla) 2% [42]
Pancreas (exocrine) 2.7–4.6% [43]
Pancreas (endogenous beta cell) 5–6% [43]
Stomach 6–10% [44]
Small intestine
Lumen
Mucosa
Serosa
2–5%
3–6%
5–9%
[45]
Large intestine lumen and mucosa
Serosa
0–2%
4–6%
[46]
Uterus 2.5% [47]
Bone marrow 1–7% [48]
Umbilical vein and arteries 2.4–3.8% [35]
Blood 5–13% [35]
Table 1. 
Oxygen levels in different tissue in-vivo.
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It indicates that oxygen levels significantly vary in various tissues of the body 
and are significantly low as compared to normoxic oxygen concentration. Initially, 
oxygen level of 21% were adopted for in vitro culturing the cells based on normal 
oxygen conditions in environment, however, latter, it was realized that the cells 
grow better in vitro when cultured in those oxygen conditions which are represen-
tative of their respective niche.
Similarly, when cells are transplanted in the body, they face hypoxic in vivo 
environmental conditions [49, 50]. A large number of grafted cells die due to harsh 
in vivo environmental conditions (such as hypoxia) at transplanted site. The cell 
death due to hypoxic microenvironment is especially considerable for tissues that 
are not vascularized and or already injured or wounded [51].
4. How hypoxic preconditioning enhance stem cell function
4.1 Effect of hypoxia on gene transcription
The survival and functioning of stem cells in hypoxic environment depends 
upon their metabolic switch controlled by hypoxia inducible factors (HIFs). HIFs are 
transcription factors that are present in eukaryotes. They have two subunits, that is, 
alpha(α) and beta(β). Their α subunit has three isoforms (HIF1-3). The post transla-
tional modification of α subunit depends on hydroxylation which is oxygen depen-
dent. When intracellular oxygen falls, α subunit forms a stable α/β dimer because 
hydroxylation did not occur. This dimer is transcriptionally active; it enters into the 
nucleus, binds to hypoxia response elements and initiates transcription of hypoxia 
sensitive genes [52, 53]. HIF3-α is the negative regulator of HIF1 and HIF2 (Figure 1).
Effect of hypoxia on HIF- α is different for different types of stem cells
GRP78-Akt axis induced by HIF1α is important in augmenting functions like 
proliferation and survival of MSCs under hypoxia [54].
4.2 Reactive oxygen species (ROS) and hypoxia
Reactive oxygen species are oxygen containing substances that are produced 
in cellular metabolism. They are detrimental to cellular functions. Hypoxic 
Figure 1. 
Mechanism of HIF1 formation and transcription of hypoxia sensitive genes. HIF (hypoxia inducible factor), 
HRE (hypoxia response element).
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preconditioning results in up regulation of Nuclear factor erythroid 2 related factor 
2 (NRF2), which is a redox sensitive transcription factor involved in regulation of 
antioxidant genes [55]. Hypoxic preconditioning results in increased glycolytic 
metabolism and decreased tricarboxylic acid (TCA) cycle and oxidative phosphory-
lation. This mechanism leads to decreased mitochondrial ROS production and 
increase in the levels of antioxidant enzymes [52, 56]. Unbalanced redox homeosta-
sis can cause stem cells aging and decreased proliferation. Hypoxic preconditioning 
augments redox metabolism [54] ROS acts paradoxically, at higher levels its cause’s 
damage, and at lower levels it plays a role of signaling molecule. ROS also controls 
the hydroxylation of HIF1a, it causes inactivation of prolyl-hydroxylase enzymes 
(PHD), as a result degradation of alpha subunit does not occur and HIF1 formation 
occurs [57].
5. Hypoxic preconditioning improves regenerative potential of cells
5.1 Effect of hypoxia on stemness and survival of stem cells
Hypoxic preconditioning improves survival and stemness of cells and has 
been investigated in a number studies. SOX2, OCT4, NANOG and c-Myc are the 
markers that show stemness of cells. It has been found that stem cells grown in 
hypoxia are more viable, have decreased apoptosis through effects on HIF1a and 
p53 pathways [58].
When cultured under hypoxic (3 or 5% oxygen) condition for 5 days, stem cell 
markers were found to be statistically higher in dental pulp MSC [59].
PI3K/Akt signaling pathway get activated in cells exposed to hypoxia which 
in turn regulates many genes of cell cycle and CDK2 resulting in increased self-
renewal and decreased apoptosis. Under hypoxic conditions cells switch their 
metabolism more towards glycolytic pathways and less towards oxidative phos-
phorylation resulting in less reactive oxygen species production (ROS) and more 
production of antioxidant enzymes [49, 60].
Hypoxia (1%) results in decreased senescence, increased lifespan of mesen-
chymal stem cells and were able to maintain proliferation rate, morphology and 
genetic stability [61]. Cryopreserved adipose derived stem cells cultured at 2 and 
5% oxygen tension resulted in increased number and viability as compared to 
counterparts grown at 21% oxygen. In addition, all stemness related gene expres-
sion NANOG, SOX-2, REX-1, and OCT-4 were much higher in hypoxia group than 
in normoxia group. Another group demonstrated the upregulation of stemness 
related genes OCT4, SOX2 and NANOG in MSC grown in 3% oxygen culture 
conditions [62, 63]. Stemness of MSCs remains preserved in hypoxic cultures. 
Hypoxia results in decreased expression of apoptotic BCL-2 and CASP3 and 
increased expression of anti-apoptotic genes [64]. Stem cells derived from apical 
papilla of wisdom teeth also showed increased proliferation and upregulation of 
SSEA4 which is an embryonic stem cell marker surface antigen. Human umbilical 
cord derived MSC grown in a culture under 5% oxygen showed better proliferation 
and maintenance of stemness [65]. MSC derived from different sources showed 
increased expression of pluripotency markers Oct4, C-Myc and Nanog when 
cultured at 5% oxygen concentration levels [66]. Low oxygen tension also helped 
iPSCs from liver cells to preserve their stemness and decrease the time to switch 
from G1 phase to S phase, increase proliferation but the physiological oxygen level 
of tissue of origin should be kept in mind because these cells were grown in 10% 
oxygen level. The same group showed that culturing these cells at very low level 
result in loss of stemness [67].
Regenerative Medicine
6
5.2 Hypoxia improves differentiation potential of cells
Most of the studies use stem cells for regenerative purposes. MSC are mul-
tipotent cells that can differentiate into adipocytes, osteoblasts, chondrocytes 
and neurons under appropriate conditions [68]. The main advantage of stem cell 
therapy is living biological replacement rather than palliation through drugs. 
The use of stem cells to replace functional loss of specific tissue is determined by 
effective differentiation [69].
The results of differentiation are controversial; this variability may be due to:
1. Use of stem cells from different sources [70].
2. Due to heterogenous population of cells with similar morphology [71].
3. Designing of delivery system for successful transplantation of stem cells [72].
Biomaterials can be designed to act as carriers for the local delivery of stem 
cells, support cells or molecular niche cues [73]. Basal nutrients, cell density, spatial 
organization, mechanical forces, growth factors and cytokines have a profound 
influence on hMSC differentiation [71]. The role of hypoxia preconditioning in 
differentiation of stem cells into other lineages seems controversial due to incon-
sistent results of various studies [74]. Different studies have used different hypoxia 
percentages with variable times. Previously, cells were usually insulted with hypoxia 
using hydrogen peroxide, however, new trigas incubators have been developed 
recently that creates the precise hypoxic conditions even for longer period of 
times [59].
It has been shown that placenta derived MSC showed up regulation of osteogenic 
genes including osteopontin (OPN), osteocalcin (OCN), and alkaline phosphatase 
(ALP) as well as increased mineralization at 5% oxygen levels [75]. Another study 
found an increased osteogenic differentiation of human MSCs cultured at 5% oxygen 
for 5 days [66]. Contrary to this, multilineage differentiation potential including 
osteogenic differentiation of tendon derived MSc was compromised in hypoxia 
cultures [76]. Minsheng Yang and colleagues found that 9% hypoxia increased 
osteogenesis whereas 1% results in decreased osteogenic potentials due to upregula-
tion of Notch 1 expression [77]. Cells cultured throughout in hypoxic culture (5%) 
showed less osteogenic potential, less mineralization as compared to cells primed 
with hypoxia (5% for 7 days). These results also emphasis that appropriate time for 
hypoxia is important to maneuver the different potentials [78].
Gale et al. analyzed the chondrogenic differentiation potential of equine 
synovial membrane and bone marrow derived MSCs and found no appreciable dif-
ference between cells cultured either at 5% oxygen or in normoxic conditions for 
28 days. The results of expression of chondrogenic genes SOX9, ACAN, and COL2b 
were also variable between the groups [79]. Similar to this Li J and Pei M found no 
significant differences in chondrogenic index between normoxic and 5% hypoxic 
culturing for 7 days in synovium derived MSCs [80]. On the contrary adipose 
derived MSC showed better chondrogenesis and upregulation of several chon-
drogenic specific genes when grown in 2% oxygen cultures [81]. Bae et al. found 
increased expression of COL2A1, ACAN, and the transcription factor SOX9 in 
synovium derived MSC cultured at 5% oxygen levels. They also observed increased 
proteoglycan, glycosaminoglycans and collagen II contents from pellets in hypoxic 
condition [82]. Henrionnet et al. observed the effects of 5% oxygen conditions on 
bone marrow derived MSC cultures for their chongrogenic potential and resulted 
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in efficient and strong overexpression of chondrogenic genes COL2A1, ACAN, 
SOX9, and COMP along with down regulation of osteogenic genes ALP, and 
RUNX2 [83].
Valorani et al. found that pre-exposure hypoxia of 2% oxygen level results in 
increased expression of adipogenic genes including peroxisome proliferator acti-
vated receptor γ (Pparγ), lipoprotein lipase (Lpl) and fatty acid binding protein 4 
(Fabp4) and adipogenesis in MSC derived from murine adipose tissue [84]. Another 
research found enhanced adipogenesis of human adipose tissue mesenchymal 
stem-cell (hAT-MSC) exposed to 2% hypoxic conditions for 7 days before shifting to 
normoxia during differentiation [85]. 2% hypoxia resulted in increased adipogenic 
differentiation of dental pulp and periodontal ligament derived stem cells [86]. 
Choi JR et al. found decreased adipogenesis and decreased expression of adipo-
genic genes including LPL, PPARc and FABP4 under hypoxia (2%) as compared to 
normoxia cultures [87]. Another research also found a decreased differentiation of 
stem cells under hypoxia [88].
5.3 Effect of hypoxia on proliferative potential of cells
Hypoxic preconditioning results in enhanced proliferation and increased colony 
forming units as compared to mesenchymal stem cells cultured in normoxia. 
Higher oxygen tensions increase oxidative stress to cells and activate apoptosis 
[55]. Zhang et al. explored the effects of 1 and 5% oxygen culture conditions on 
rat bone marrow derived MSC and compared them with their counter parts at 18% 
oxygen level cultures. They found significant increase in proliferation along with 
upregulation of BCL2 (antiapoptotic gene) and down regulation of BAX (apop-
totic gene) [89]. About 5% oxygen tension resulted in greater size, cell number and 
cell density of MSC colonies [90]. Antebi et al. evaluated the potential of cells at 
different oxygen concentrations and found that proliferative potentials of porcine 
MSC was higher at 1, 2, and 5% oxygen tensions as compared to normoxic condi-
tions. They also found that 48 hour hypoxia in their study resulted in more pro-
liferation as compared to proliferative potential of cells when cultured for longer 
times (10 days) [64]. Elabd et al. suggested that hypoxic preconditioning should 
be used as a strategy for in vitro expansion of MSC before their clinical use. They 
cultured human bone marrow MSCs in 5 and 20% oxygen and observed greater 
effects of hypoxia not on the regenerative potentials but also on the gene expres-
sions of hypoxia exposed MSCs [91]. Notch2-c-Myc signaling cause’s proliferation 
under hypoxia and inhibits apoptosis. Hypoxia can have a great effect on prolif-
eration of MSCs [92]. Hypoxia (1%) increases the proliferation not only in early 
passages but also in late passages as compared to normoxic cultures and extends 
the lifespan of MSCs [61]. Significantly higher number of cells as well as increased 
viability of ADSC occurs in hypoxic conditions [93]. Rat bone marrow MSC 
cultured at 5% oxygen levels exhibited increased number of colonies and shorter 
population doubling time as compared to normoxic cultured cells [94]. Asadpoor 
Dezaki et al. showed increased expansion, population doublings, viability and 
colony forming unit fibroblasts in a group cultured in 2.5% oxygen tension than 
normoxia group [95].
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Acronyms and abbreviation
MSCs mesenchymal stem cells
ESC embryonic stem cells
iPSC induced pluripotent stem cells
SOD superoxide dismutase activity
HIFs hypoxia inducible factors
HRE hypoxia response element
ROS reactive oxygen species
PHD prolyl-hydroxylase enzymes
OPN osteopontin
OCN osteocalcin
ALP alkaline phosphatase
Pparγ peroxisome proliferator activated receptor γ
Lpl lipoprotein lipase
Fabp4 fatty acid binding protein 4
NRF2 nuclear factor erythroid 2 related factor 2
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